HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: db08-0226v1 57/8/2012    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Satapati, S. Articles by Burgess, S. C. PubMed PubMed Citation Articles by Satapati, S. Articles by Burgess, S. C. Social Bookmarking                What's this?

Partial Resistance to Peroxisome Proliferator–Activated Receptor- Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism

¹ The Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas
² Department of Molecular and Cell Biology, University of Texas at Dallas, Richardson, Texas
³ Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas
⁴ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
⁵ Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas

Corresponding author: Shawn C. Burgess, shawn.burgess{at}utsouthwestern.edu

OBJECTIVE—Fluxes through mitochondrial pathways are defective in insulin-resistant skeletal muscle, but it is unclear whether similar mitochondrial defects play a role in the liver during insulin resistance and/or diabetes. The purpose of this study is to determine whether abnormal mitochondrial metabolism plays a role in the dysregulation of both hepatic fat and glucose metabolism during diabetes.

RESEARCH DESIGN AND METHODS—Mitochondrial fluxes were measured using ²H/¹³C tracers and nuclear magnetic resonance spectroscopy in ZDF rats during early and advanced diabetes. To determine whether defects in hepatic fat oxidation can be corrected by peroxisome proliferator–activated receptor (PPAR-)- activation, rats were treated with WY14,643 for 3 weeks before tracer administration.

RESULTS—Hepatic mitochondrial fat oxidation in the diabetic liver was impaired twofold secondary to decreased ketogenesis, but tricarboxylic acid (TCA) cycle activity and pyruvate carboxylase flux were normal in newly diabetic rats and elevated in older rats. Treatment of diabetic rats with a PPAR– agonist induced hepatic fat oxidation via ketogenesis and hepatic TCA cycle activity but failed to lower fasting glycemia or endogenous glucose production. In fact, PPAR- agonism overstimulated mitochondrial TCA cycle flux and induced pyruvate carboxylase flux and gluconeogenesis in lean rats.

CONCLUSIONS—The impairment of certain mitochondrial fluxes, but preservation or induction of others, suggests a complex defect in mitochondrial metabolism in the diabetic liver. These data indicate an important codependence between hepatic fat oxidation and gluconeogenesis in the normal and diabetic state and potentially explain the sometimes equivocal effect of PPAR- agonists on glycemia.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?